Changes Jan. 6, 2022
The following is a list of changes on monitored regulatory lists which occurred between Jan. 6, 2022 and Jan. 6, 2022.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Registered substances
- (+/-) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate
- (+/-)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol
- (2-methylpropyl)lithium;isobutyllithium
- (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene;reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene
- (2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate
- (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one;5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one
- (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one;5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one
- (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide
- (3E)-1,7,7-trimethyl-3-[(4- methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
- (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl;N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide
- .sc.d.sc.-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
- 1,1,1,3,3,3-hexafluoro-2-methoxypropane
- 1,2,4-Triazolo[4,3-c]pyrimidine-3(2H)-thione, 5-ethoxy-7-fluoro-
- 1,3,5-Triazine, 2,4,6-tris([1,1'-biphenyl]-4-yl)-
- 1,3,5-Triazine-2,4-diamine, N2-[(1R,2S)-2,3-dihydro-2,6-dimethyl-1H-inden-1-yl]-6-(1-fluoroethyl)-
- 1,3-Diazaspiro[4.5]decane-2,4-dione, 8-methoxy-, sodium salt (1:1), cis-
- 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing < 0.1 % 4-chloroaniline (EC No 203-401-0)];[containing ≥ 0.1 % 4-chloroaniline (EC No 203-401-0)]
- 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing < 0.1 % 4-chloroaniline (EC No 203-401-0)];[containing ≥ 0.1 % 4-chloroaniline (EC No 203-401-0)]
- 1-(2-isopropylphenyl)-1-phenylethane;1-(3-isopropylphenyl)-1-phenylethane;reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane
- 1-Azabicyclo[2.2.2]octane, 3-methylene-
- 1-Naphthalenol, 2-methyl-, 1-acetate
- 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
- 1H,5H-Pyrazolo[1,2-a]pyrazol-1-one, 2,3-diamino-6,7-dihydro-, methanesulfonate (1:2)
- 1H-Benzimidazole-5,7-disulfonic acid, 2,2'-(1,4-phenylene)bis-, sodium salt (1:2)
- 1H-Benzimidazole-5,7-disulfonic acid, 2,2'-(1,4-phenylene)bis-, sodium salt (1:2)
- 2(3H)-Furanone, dihydro-3-hydroxy-
- 2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex;reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex
- 2-(formylamino)-3-thiophenecarboxylic acid;2-formamido-3-thiophenecarboxylic acid
- 2-Propenamide, N-(2-hydroxyethyl)-
- 2-Pyrimidinamine, 4-methyl-N-phenyl-6-(1-propyn-1-yl)-
- 2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)oxy]ethanol hydrochloride
- 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanaminium bromide
- 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanaminium bromide
- 2H-1-Benzopyran-2-carboxylic acid, 6-fluoro-3,4-dihydro-
- 2H-1-Benzopyran-2-carboxylic acid, 6-fluoro-3,4-dihydro-
- 2H-1-Benzopyran-2-carboxylic acid, 6-fluoro-3,4-dihydro-
- 2H-Benzimidazole-2-thione, 5-(difluoromethoxy)-1,3-dihydro-
- 2H-Benzimidazole-2-thione, 5-(difluoromethoxy)-1,3-dihydro-
- 2H-Benzimidazole-2-thione, 5-(difluoromethoxy)-1,3-dihydro-
- 2H-Benzimidazole-2-thione, 5-(difluoromethoxy)-1,3-dihydro-
- 3,7,11-trimethyl-trans-6,10-dodecadienal;reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal
- 3-Pyridinemethanol, hydrofluoride (1:1)
- 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
- 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt
- 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium;reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium
- 4-chloro-5-methylbenzotriazole sodium salt;5-chloro-4-methylbenzotriazole sodium salt;reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt
- 4-decyl-1,3-oxazolidin-2-one;4-decyloxazolidin-2-one
- 5,7-dichloro-4-(4-fluorophenoxy)quinoline;quinoxyfen (ISO)
- 5-nitro-1H-pyrazole
- 5H-Cyclopenta[h]quinazoline, 6,7,8,9-tetrahydro-7,7,8,9,9-pentamethyl-
- 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0.5 % formamide (EC No 200-842-0)];[containing ≥ 0.5 % formamide (EC No 200-842-0) ]
- Acetic acid, 2-cyano-2-[3-[(3-methoxypropyl)amino]-2-cyclohexen-1-ylidene]-, 2-ethoxyethyl ester, (2Z)-
- Aluminum magnesium vanadium oxide
- Amines, N-(3-aminopropyl)-N-(C16-18 and C18-unsatd. alkyl)trimethylenedi-
- Benzene, 1-(2-chloro-1,2-diphenylethenyl)-4-(2-chloroethoxy)-
- Benzene, ethylenated, residues, distn. lights
- Benzeneacetic acid, .alpha.,.alpha.'-(1,2-ethanediyldiimino)bis[2-hydroxy-5-sulfo-
- Benzenemethanol, lithium salt (1:1)
- Benzoic acid, 4-[[[4-[(1-oxo-2-propen-1-yl)oxy]butoxy]carbonyl]oxy]-, 1,1'-(2-methyl-1,4-phenylene) ester
- Bis(5-amino-2-hydroxyphenyl)methane dihydrochloride
- Bis(5-amino-2-hydroxyphenyl)methane dihydrochloride
- Bis(5-amino-2-hydroxyphenyl)methane dihydrochloride
- Cobaltate(1-), tetracarbonyl-, sodium (1:1), (T-4)-
- Cobaltate(3-), hexakis(cyano-.kappa.C)-, zinc, hydrate (2:3:12), (OC-6-11)-
- Commiphora myrrha, ext.
- D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
- Ethane, 1,1,2-trichloro-1,2-difluoro-
- Ferrate(2-), [[N,N'-1,2-ethanediylbis[N-[(carboxy-.kappa.O)methyl]glycinato-.kappa.N,.kappa.O]](4-)]-, (OC-6-21)-
- Formaldehyde, reaction products with bisphenol A and diethanolamine, propoxylated
- Heparin, phenylmethyl ester
- Hexane, 1,6-diisocyanato-2,2,4(or 2,4,4)-trimethyl-
- Hydrocarbons, C10, aromatics, <1% naphthalene
- Hydrocarbons, C11-C13, isoalkanes, <2% aromatics
- Isooctadecanoic acid, methyl ester
- N,N'-diallyl-1,3-diaminopropane dihydrochloride
- N,N-dimethyl-alkyl-1-amines, reaction products with alkali hydroxide and chloroacetic acid
- NEODYMIUM DEHP 45 or 55
- Nickel alloy, base, Ni 54.0-57.0,Ti 43-46,C 0-0.07,Co 0-0.05,Fe 0-0.05,O 0-0.05,Nb 0-0.025,Cr 0-0.01,Cu 0-0.01,H 0-0.005 (UNS N01555)
- Phenol, 2-(1-methylheptyl)-4,6-dinitro-
- Phenol, 2-amino-5-ethyl-, hydrochloride (1:1)
- Phosphinic acid, P,P-diethyl-, zinc salt (2:1)
- Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, monophenyl ester
- Phosphorothioic acid, O,O-bis(2-methylpropyl) ester, sodium salt (1:1)
- Propanoic acid, 2-[4-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]-, (2R)-
- Propanoic acid, 3-chloro-, 4-chlorobutyl ester
- Propionaldehyde, reaction product with formaldehyde
- Reaction Mass of 3,3-diphenylhexamethyltrisiloxane and 3,3,5,5-tetraphenylhexamethyltetrasiloxane
- Reaction Mass of 3,3-diphenylhexamethyltrisiloxane and 3,3,5,5-tetraphenylhexamethyltetrasiloxane
- Reaction Mass of 4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-one and 4-(2,6,6-trimethylcyclohex-2-en-1-yl)butan-2-one and 4-[(1RS,6RS)-2,2,6-trimethylcyclohexyl]butan-2-one and (2RS,4aRS)-2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol and 2,5,5-trimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-ol
- Reaction mass of (R)-2-(5-methoxy-1,5-dimethylhexyl)-oxirane and (S)-2-(5-methoxy-1,5-dimethylhexyl)-oxirane
- Reaction mass of 35044-57-6 and 35044-58-7 and 35044-59-8
- Reaction mass of 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate and 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl isobutyrate
- Rosin, dimers, calcium zinc salts
- Silver sodium zirconium hydrogenphosphate
- Stannate (Sn(OH)62-), zinc (1:1), (OC-6-11)-
- Synthetic fibers, alk. earth silicate
- Synthetic wollastonite
- THI streams (THI RF60, THI RF30, THI TM)
- [containing < 0.5 % N,N-dimethylformamide (EC no 200-679-5)];[containing ≥ 0.5 % N,N-dimethylformamide (EC No 200-679-5)];potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate
- aluminum;3-oxobutanoate